Del Monte Pacific Limited (SGX:D03)

Regulus Therapeutics Revenue

In the fiscal year ending April 30, 2025, Del Monte Pacific had annual revenue of $789.46M USD, down -67.48%. Del Monte Pacific had revenue of $191.91M in the quarter ending April 30, 2025, a decrease of -67.87%.

• Revenue: $789.46M
• Revenue Growth: -67.48%
• P/S Ratio: 0.16
• Revenue / Employee: $140.97K
• Employees: 5,600
• Market Cap: 161.35M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2025	789.46M	-1.64B	-67.48%
Apr 30, 2024	2.43B	6.42M	0.27%
Apr 30, 2023	2.42B	79.23M	3.38%
Apr 30, 2022	2.34B	179.38M	8.29%
Apr 30, 2021	2.16B	34.37M	1.61%